Global Oncology Drug Discovery Services Market Size, Status and Forecast 2024-2031

Report ID: 919315 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncology Drug Discovery Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Identification Service
        1.2.3 Authentication Service
        1.2.4 Hit-to-lead and Lead Optimization Services
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Oncology Drug Discovery Services Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Research Institutes
        1.3.3 Pharmaceutical Companies
        1.3.4 Biotechnology Companies
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Oncology Drug Discovery Services Market Perspective (2016-2027)
    2.2 Oncology Drug Discovery Services Growth Trends by Regions
        2.2.1 Oncology Drug Discovery Services Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Oncology Drug Discovery Services Historic Market Share by Regions (2016-2021)
        2.2.3 Oncology Drug Discovery Services Forecasted Market Size by Regions (2022-2027)
    2.3 Oncology Drug Discovery Services Industry Dynamic
        2.3.1 Oncology Drug Discovery Services Market Trends
        2.3.2 Oncology Drug Discovery Services Market Drivers
        2.3.3 Oncology Drug Discovery Services Market Challenges
        2.3.4 Oncology Drug Discovery Services Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Oncology Drug Discovery Services Players by Revenue
        3.1.1 Global Top Oncology Drug Discovery Services Players by Revenue (2016-2021)
        3.1.2 Global Oncology Drug Discovery Services Revenue Market Share by Players (2016-2021)
    3.2 Global Oncology Drug Discovery Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Oncology Drug Discovery Services Revenue
    3.4 Global Oncology Drug Discovery Services Market Concentration Ratio
        3.4.1 Global Oncology Drug Discovery Services Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncology Drug Discovery Services Revenue in 2020
    3.5 Oncology Drug Discovery Services Key Players Head office and Area Served
    3.6 Key Players Oncology Drug Discovery Services Product Solution and Service
    3.7 Date of Enter into Oncology Drug Discovery Services Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Drug Discovery Services Breakdown Data by Type
    4.1 Global Oncology Drug Discovery Services Historic Market Size by Type (2016-2021)
    4.2 Global Oncology Drug Discovery Services Forecasted Market Size by Type (2022-2027)

5 Oncology Drug Discovery Services Breakdown Data by Application
    5.1 Global Oncology Drug Discovery Services Historic Market Size by Application (2016-2021)
    5.2 Global Oncology Drug Discovery Services Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Oncology Drug Discovery Services Market Size (2016-2027)
    6.2 North America Oncology Drug Discovery Services Market Size by Type
        6.2.1 North America Oncology Drug Discovery Services Market Size by Type (2016-2021)
        6.2.2 North America Oncology Drug Discovery Services Market Size by Type (2022-2027)
        6.2.3 North America Oncology Drug Discovery Services Market Size by Type (2016-2027)
    6.3 North America Oncology Drug Discovery Services Market Size by Application
        6.3.1 North America Oncology Drug Discovery Services Market Size by Application (2016-2021)
        6.3.2 North America Oncology Drug Discovery Services Market Size by Application (2022-2027)
        6.3.3 North America Oncology Drug Discovery Services Market Size by Application (2016-2027)
    6.4 North America Oncology Drug Discovery Services Market Size by Country
        6.4.1 North America Oncology Drug Discovery Services Market Size by Country (2016-2021)
        6.4.2 North America Oncology Drug Discovery Services Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Oncology Drug Discovery Services Market Size (2016-2027)
    7.2 Europe Oncology Drug Discovery Services Market Size by Type
        7.2.1 Europe Oncology Drug Discovery Services Market Size by Type (2016-2021)
        7.2.2 Europe Oncology Drug Discovery Services Market Size by Type (2022-2027)
        7.2.3 Europe Oncology Drug Discovery Services Market Size by Type (2016-2027)
    7.3 Europe Oncology Drug Discovery Services Market Size by Application
        7.3.1 Europe Oncology Drug Discovery Services Market Size by Application (2016-2021)
        7.3.2 Europe Oncology Drug Discovery Services Market Size by Application (2022-2027)
        7.3.3 Europe Oncology Drug Discovery Services Market Size by Application (2016-2027)
    7.4 Europe Oncology Drug Discovery Services Market Size by Country
        7.4.1 Europe Oncology Drug Discovery Services Market Size by Country (2016-2021)
        7.4.2 Europe Oncology Drug Discovery Services Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Oncology Drug Discovery Services Market Size (2016-2027)
    8.2 Asia-Pacific Oncology Drug Discovery Services Market Size by Type
        8.2.1 Asia-Pacific Oncology Drug Discovery Services Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Oncology Drug Discovery Services Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Oncology Drug Discovery Services Market Size by Type (2016-2027)
    8.3 Asia-Pacific Oncology Drug Discovery Services Market Size by Application
        8.3.1 Asia-Pacific Oncology Drug Discovery Services Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Oncology Drug Discovery Services Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Oncology Drug Discovery Services Market Size by Application (2016-2027)
    8.4 Asia-Pacific Oncology Drug Discovery Services Market Size by Region
        8.4.1 Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Oncology Drug Discovery Services Market Size (2016-2027)
    9.2 Latin America Oncology Drug Discovery Services Market Size by Type
        9.2.1 Latin America Oncology Drug Discovery Services Market Size by Type (2016-2021)
        9.2.2 Latin America Oncology Drug Discovery Services Market Size by Type (2022-2027)
        9.2.3 Latin America Oncology Drug Discovery Services Market Size by Type (2016-2027)
    9.3 Latin America Oncology Drug Discovery Services Market Size by Application
        9.3.1 Latin America Oncology Drug Discovery Services Market Size by Application (2016-2021)
        9.3.2 Latin America Oncology Drug Discovery Services Market Size by Application (2022-2027)
        9.3.3 Latin America Oncology Drug Discovery Services Market Size by Application (2016-2027)
    9.4 Latin America Oncology Drug Discovery Services Market Size by Country
        9.4.1 Latin America Oncology Drug Discovery Services Market Size by Country (2016-2021)
        9.4.2 Latin America Oncology Drug Discovery Services Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Oncology Drug Discovery Services Market Size (2016-2027)
    10.2 Middle East & Africa Oncology Drug Discovery Services Market Size by Type
        10.2.1 Middle East & Africa Oncology Drug Discovery Services Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Oncology Drug Discovery Services Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Oncology Drug Discovery Services Market Size by Type (2016-2027)
    10.3 Middle East & Africa Oncology Drug Discovery Services Market Size by Application
        10.3.1 Middle East & Africa Oncology Drug Discovery Services Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Oncology Drug Discovery Services Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Oncology Drug Discovery Services Market Size by Application (2016-2027)
    10.4 Middle East & Africa Oncology Drug Discovery Services Market Size by Country
        10.4.1 Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Charles River
        11.1.1 Charles River Company Details
        11.1.2 Charles River Business Overview
        11.1.3 Charles River Oncology Drug Discovery Services Introduction
        11.1.4 Charles River Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.1.5 Charles River Recent Development
    11.2 Evotec
        11.2.1 Evotec Company Details
        11.2.2 Evotec Business Overview
        11.2.3 Evotec Oncology Drug Discovery Services Introduction
        11.2.4 Evotec Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.2.5 Evotec Recent Development
    11.3 GE Healthcare Life Sciences
        11.3.1 GE Healthcare Life Sciences Company Details
        11.3.2 GE Healthcare Life Sciences Business Overview
        11.3.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Introduction
        11.3.4 GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.3.5 GE Healthcare Life Sciences Recent Development
    11.4 GenScript
        11.4.1 GenScript Company Details
        11.4.2 GenScript Business Overview
        11.4.3 GenScript Oncology Drug Discovery Services Introduction
        11.4.4 GenScript Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.4.5 GenScript Recent Development
    11.5 Horizon Discovery
        11.5.1 Horizon Discovery Company Details
        11.5.2 Horizon Discovery Business Overview
        11.5.3 Horizon Discovery Oncology Drug Discovery Services Introduction
        11.5.4 Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.5.5 Horizon Discovery Recent Development
    11.6 TCG Lifesciences
        11.6.1 TCG Lifesciences Company Details
        11.6.2 TCG Lifesciences Business Overview
        11.6.3 TCG Lifesciences Oncology Drug Discovery Services Introduction
        11.6.4 TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.6.5 TCG Lifesciences Recent Development
    11.7 Zumutor
        11.7.1 Zumutor Company Details
        11.7.2 Zumutor Business Overview
        11.7.3 Zumutor Oncology Drug Discovery Services Introduction
        11.7.4 Zumutor Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.7.5 Zumutor Recent Development
    11.8 ChemPartner
        11.8.1 ChemPartner Company Details
        11.8.2 ChemPartner Business Overview
        11.8.3 ChemPartner Oncology Drug Discovery Services Introduction
        11.8.4 ChemPartner Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.8.5 ChemPartner Recent Development
    11.9 Aquila BioMedical
        11.9.1 Aquila BioMedical Company Details
        11.9.2 Aquila BioMedical Business Overview
        11.9.3 Aquila BioMedical Oncology Drug Discovery Services Introduction
        11.9.4 Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.9.5 Aquila BioMedical Recent Development
    11.10 Onconova
        11.10.1 Onconova Company Details
        11.10.2 Onconova Business Overview
        11.10.3 Onconova Oncology Drug Discovery Services Introduction
        11.10.4 Onconova Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.10.5 Onconova Recent Development
    11.11 Vichem Chemie
        11.11.1 Vichem Chemie Company Details
        11.11.2 Vichem Chemie Business Overview
        11.11.3 Vichem Chemie Oncology Drug Discovery Services Introduction
        11.11.4 Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.11.5 Vichem Chemie Recent Development
    11.12 GVK Biosciences
        11.12.1 GVK Biosciences Company Details
        11.12.2 GVK Biosciences Business Overview
        11.12.3 GVK Biosciences Oncology Drug Discovery Services Introduction
        11.12.4 GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.12.5 GVK Biosciences Recent Development
    11.13 NuChem Therapeutics
        11.13.1 NuChem Therapeutics Company Details
        11.13.2 NuChem Therapeutics Business Overview
        11.13.3 NuChem Therapeutics Oncology Drug Discovery Services Introduction
        11.13.4 NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.13.5 NuChem Therapeutics Recent Development
    11.14 Syncom
        11.14.1 Syncom Company Details
        11.14.2 Syncom Business Overview
        11.14.3 Syncom Oncology Drug Discovery Services Introduction
        11.14.4 Syncom Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.14.5 Syncom Recent Development
    11.15 Envigo
        11.15.1 Envigo Company Details
        11.15.2 Envigo Business Overview
        11.15.3 Envigo Oncology Drug Discovery Services Introduction
        11.15.4 Envigo Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.15.5 Envigo Recent Development
    11.16 DiverChim
        11.16.1 DiverChim Company Details
        11.16.2 DiverChim Business Overview
        11.16.3 DiverChim Oncology Drug Discovery Services Introduction
        11.16.4 DiverChim Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.16.5 DiverChim Recent Development
    11.17 Aurora
        11.17.1 Aurora Company Details
        11.17.2 Aurora Business Overview
        11.17.3 Aurora Oncology Drug Discovery Services Introduction
        11.17.4 Aurora Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.17.5 Aurora Recent Development
    11.18 HD Biosciences
        11.18.1 HD Biosciences Company Details
        11.18.2 HD Biosciences Business Overview
        11.18.3 HD Biosciences Oncology Drug Discovery Services Introduction
        11.18.4 HD Biosciences Revenue in Oncology Drug Discovery Services Business (2016-2021)
        11.18.5 HD Biosciences Recent Development
    11.18 WuXi AppTec
        .1 WuXi AppTec Company Details
        .2 WuXi AppTec Business Overview
        .3 WuXi AppTec Oncology Drug Discovery Services Introduction
        .4 WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2016-2021)
        .5 WuXi AppTec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Oncology Drug Discovery Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Identification Service
    Table 3. Key Players of Authentication Service
    Table 4. Key Players of Hit-to-lead and Lead Optimization Services
    Table 5. Key Players of Others
    Table 6. Global Oncology Drug Discovery Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Oncology Drug Discovery Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Oncology Drug Discovery Services Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Oncology Drug Discovery Services Market Share by Regions (2016-2021)
    Table 10. Global Oncology Drug Discovery Services Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Oncology Drug Discovery Services Market Share by Regions (2022-2027)
    Table 12. Oncology Drug Discovery Services Market Trends
    Table 13. Oncology Drug Discovery Services Market Drivers
    Table 14. Oncology Drug Discovery Services Market Challenges
    Table 15. Oncology Drug Discovery Services Market Restraints
    Table 16. Global Oncology Drug Discovery Services Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Oncology Drug Discovery Services Market Share by Players (2016-2021)
    Table 18. Global Top Oncology Drug Discovery Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drug Discovery Services as of 2020)
    Table 19. Ranking of Global Top Oncology Drug Discovery Services Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Oncology Drug Discovery Services Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Oncology Drug Discovery Services Product Solution and Service
    Table 23. Date of Enter into Oncology Drug Discovery Services Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Oncology Drug Discovery Services Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Oncology Drug Discovery Services Revenue Market Share by Type (2016-2021)
    Table 27. Global Oncology Drug Discovery Services Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Oncology Drug Discovery Services Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Oncology Drug Discovery Services Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Oncology Drug Discovery Services Revenue Market Share by Application (2016-2021)
    Table 31. Global Oncology Drug Discovery Services Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Oncology Drug Discovery Services Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Oncology Drug Discovery Services Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Oncology Drug Discovery Services Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Oncology Drug Discovery Services Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Oncology Drug Discovery Services Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Oncology Drug Discovery Services Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Oncology Drug Discovery Services Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Oncology Drug Discovery Services Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Oncology Drug Discovery Services Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Oncology Drug Discovery Services Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Oncology Drug Discovery Services Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Oncology Drug Discovery Services Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Oncology Drug Discovery Services Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Oncology Drug Discovery Services Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Oncology Drug Discovery Services Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Oncology Drug Discovery Services Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Oncology Drug Discovery Services Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Oncology Drug Discovery Services Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Oncology Drug Discovery Services Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Oncology Drug Discovery Services Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Oncology Drug Discovery Services Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Oncology Drug Discovery Services Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Oncology Drug Discovery Services Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Oncology Drug Discovery Services Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Oncology Drug Discovery Services Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Oncology Drug Discovery Services Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Oncology Drug Discovery Services Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Charles River Company Details
    Table 64. Charles River Business Overview
    Table 65. Charles River Oncology Drug Discovery Services Product
    Table 66. Charles River Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 67. Charles River Recent Development
    Table 68. Evotec Company Details
    Table 69. Evotec Business Overview
    Table 70. Evotec Oncology Drug Discovery Services Product
    Table 71. Evotec Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 72. Evotec Recent Development
    Table 73. GE Healthcare Life Sciences Company Details
    Table 74. GE Healthcare Life Sciences Business Overview
    Table 75. GE Healthcare Life Sciences Oncology Drug Discovery Services Product
    Table 76. GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 77. GE Healthcare Life Sciences Recent Development
    Table 78. GenScript Company Details
    Table 79. GenScript Business Overview
    Table 80. GenScript Oncology Drug Discovery Services Product
    Table 81. GenScript Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 82. GenScript Recent Development
    Table 83. Horizon Discovery Company Details
    Table 84. Horizon Discovery Business Overview
    Table 85. Horizon Discovery Oncology Drug Discovery Services Product
    Table 86. Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 87. Horizon Discovery Recent Development
    Table 88. TCG Lifesciences Company Details
    Table 89. TCG Lifesciences Business Overview
    Table 90. TCG Lifesciences Oncology Drug Discovery Services Product
    Table 91. TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 92. TCG Lifesciences Recent Development
    Table 93. Zumutor Company Details
    Table 94. Zumutor Business Overview
    Table 95. Zumutor Oncology Drug Discovery Services Product
    Table 96. Zumutor Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 97. Zumutor Recent Development
    Table 98. ChemPartner Company Details
    Table 99. ChemPartner Business Overview
    Table 100. ChemPartner Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 101. ChemPartner Recent Development
    Table 102. Aquila BioMedical Company Details
    Table 103. Aquila BioMedical Business Overview
    Table 104. Aquila BioMedical Oncology Drug Discovery Services Product
    Table 105. Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 106. Aquila BioMedical Recent Development
    Table 107. Onconova Company Details
    Table 108. Onconova Business Overview
    Table 109. Onconova Oncology Drug Discovery Services Product
    Table 110. Onconova Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 111. Onconova Recent Development
    Table 112. Vichem Chemie Company Details
    Table 113. Vichem Chemie Business Overview
    Table 114. Vichem Chemie Oncology Drug Discovery Services Product
    Table 115. Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 116. Vichem Chemie Recent Development
    Table 117. GVK Biosciences Company Details
    Table 118. GVK Biosciences Business Overview
    Table 119. GVK Biosciences Oncology Drug Discovery Services Product
    Table 120. GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 121. GVK Biosciences Recent Development
    Table 122. NuChem Therapeutics Company Details
    Table 123. NuChem Therapeutics Business Overview
    Table 124. NuChem Therapeutics Oncology Drug Discovery Services Product
    Table 125. NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 126. NuChem Therapeutics Recent Development
    Table 127. Syncom Company Details
    Table 128. Syncom Business Overview
    Table 129. Syncom Oncology Drug Discovery Services Product
    Table 130. Syncom Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 131. Syncom Recent Development
    Table 132. Envigo Company Details
    Table 133. Envigo Business Overview
    Table 134. Envigo Oncology Drug Discovery Services Product
    Table 135. Envigo Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 136. Envigo Recent Development
    Table 137. DiverChim Company Details
    Table 138. DiverChim Business Overview
    Table 139. DiverChim Oncology Drug Discovery Services Product
    Table 140. DiverChim Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 141. DiverChim Recent Development
    Table 142. Aurora Company Details
    Table 143. Aurora Business Overview
    Table 144. Aurora Oncology Drug Discovery Services Product
    Table 145. Aurora Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 146. Aurora Recent Development
    Table 147. HD Biosciences Company Details
    Table 148. HD Biosciences Business Overview
    Table 149. HD Biosciences Oncology Drug Discovery Services Product
    Table 150. HD Biosciences Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 151. HD Biosciences Recent Development
    Table 152. WuXi AppTec Company Details
    Table 153. WuXi AppTec Business Overview
    Table 154. WuXi AppTec Oncology Drug Discovery Services Product
    Table 155. WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2016-2021) & (US$ Million)
    Table 156. WuXi AppTec Recent Development
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Drug Discovery Services Market Share by Type: 2020 VS 2027
    Figure 2. Identification Service Features
    Figure 3. Authentication Service Features
    Figure 4. Hit-to-lead and Lead Optimization Services Features
    Figure 5. Others Features
    Figure 6. Global Oncology Drug Discovery Services Market Share by Application: 2020 VS 2027
    Figure 7. Research Institutes Case Studies
    Figure 8. Pharmaceutical Companies Case Studies
    Figure 9. Biotechnology Companies Case Studies
    Figure 10. Others Case Studies
    Figure 11. Oncology Drug Discovery Services Report Years Considered
    Figure 12. Global Oncology Drug Discovery Services Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Oncology Drug Discovery Services Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Oncology Drug Discovery Services Market Share by Regions: 2020 VS 2027
    Figure 15. Global Oncology Drug Discovery Services Market Share by Regions (2022-2027)
    Figure 16. Global Oncology Drug Discovery Services Market Share by Players in 2020
    Figure 17. Global Top Oncology Drug Discovery Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drug Discovery Services as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Oncology Drug Discovery Services Revenue in 2020
    Figure 19. Global Oncology Drug Discovery Services Revenue Market Share by Type (2016-2021)
    Figure 20. Global Oncology Drug Discovery Services Revenue Market Share by Type (2022-2027)
    Figure 21. North America Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Oncology Drug Discovery Services Market Share by Type (2016-2027)
    Figure 23. North America Oncology Drug Discovery Services Market Share by Application (2016-2027)
    Figure 24. North America Oncology Drug Discovery Services Market Share by Country (2016-2027)
    Figure 25. United States Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Oncology Drug Discovery Services Market Share by Type (2016-2027)
    Figure 29. Europe Oncology Drug Discovery Services Market Share by Application (2016-2027)
    Figure 30. Europe Oncology Drug Discovery Services Market Share by Country (2016-2027)
    Figure 31. Germany Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Oncology Drug Discovery Services Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Oncology Drug Discovery Services Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Oncology Drug Discovery Services Market Share by Region (2016-2027)
    Figure 41. China Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Oncology Drug Discovery Services Market Share by Type (2016-2027)
    Figure 49. Latin America Oncology Drug Discovery Services Market Share by Application (2016-2027)
    Figure 50. Latin America Oncology Drug Discovery Services Market Share by Country (2016-2027)
    Figure 51. Mexico Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Oncology Drug Discovery Services Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Oncology Drug Discovery Services Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Oncology Drug Discovery Services Market Share by Country (2016-2027)
    Figure 57. Turkey Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Oncology Drug Discovery Services Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Charles River Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 61. Evotec Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 62. GE Healthcare Life Sciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 63. GenScript Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 64. Horizon Discovery Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 65. TCG Lifesciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 66. Zumutor Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 67. ChemPartner Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 68. Aquila BioMedical Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 69. Onconova Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 70. Vichem Chemie Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 71. GVK Biosciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 72. NuChem Therapeutics Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 73. Syncom Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 74. Envigo Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 75. DiverChim Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 76. Aurora Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 77. HD Biosciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 78. WuXi AppTec Revenue Growth Rate in Oncology Drug Discovery Services Business (2016-2021)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Charles River
Evotec
GE Healthcare Life Sciences
GenScript
Horizon Discovery
TCG Lifesciences
Zumutor
ChemPartner
Aquila BioMedical
Onconova
Vichem Chemie
GVK Biosciences
NuChem Therapeutics
Syncom
Envigo
DiverChim
Aurora
HD Biosciences
WuXi AppTec
Frequently Asked Questions
Oncology Drug Discovery Services report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Drug Discovery Services report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Drug Discovery Services report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Chatbot in BFSI

A Chatbot (called bot for short) is a computer program designed to mimic conversation with human  ... Read More

Account Aggregators

Account Aggregators aim to consolidate the financial data spread across various financial institu ... Read More